
Managing the Side Effects of GLP-1 Therapy
Nausea and constipation are common early in GLP-1 therapy. Here’s what actually helps, and when a symptom is worth a call to your care team.
MacArthur Gastroenterology brings 40+ years of clinical expertise together with physician-supervised programs for fatty liver screening and medical weight management.
From routine colonoscopy and endoscopy to complex GI conditions, our board-certified physicians provide diagnostic and therapeutic care across the full range of digestive health.
EGD is an outpatient procedure using a flexible video endoscope to examine the esophagus, stomach, and duodenum. Performed by Dr. Peterson, it gives a clear, direct view of the upper digestive tract.
Flexible sigmoidoscopy uses a thin, flexible scope with a light and camera to examine the rectum and lower (sigmoid and descending) colon. Learn more from the National Institute of Health (NIH).
Colonoscopy uses a flexible fiber optic scope to examine the full colon, from the cecum to the descending colon. Dr. Peterson’s scoping expertise makes this exam both thorough and life-saving.
A quick, non-invasive Velacur® scan detects fatty liver disease and liver stiffness in minutes, no needles, no prep required.
Physician-supervised programs, including GLP-1 therapy when appropriate, designed around your metabolic health and monitored by our clinical team.
Dr. Peterson has served the Oakland community for over four decades, combining deep clinical experience with a personal, unhurried approach to every patient relationship.
Practical guidance on gastroenterology, fatty liver disease, and physician-supervised weight loss, written by our clinical team.

Nausea and constipation are common early in GLP-1 therapy. Here’s what actually helps, and when a symptom is worth a call to your care team.

Fatty liver disease is often reversible when caught early. Here’s what the research actually shows about how much change is realistic.

“Compounded” gets used a lot without explanation. Here’s what it actually means, and what it doesn’t, for your weight management plan.

Fructose isn’t processed the same way as other sugars. Research increasingly points to it as a direct driver of fat buildup in the liver.

Most clinical guidelines use a BMI of 30, or 27 with a related health condition, as a starting point. Here’s what that actually means and doesn’t mean.

MASLD, MASH, and fibrosis get used interchangeably, but they’re not the same thing. Here’s what each one actually means.